Sterol Carrier Protein-2: Binding Protein for Endocannabinoids

Molecular Neurobiology

Volumn 50, Issue 1, 2014, Pages 149-158

  Liedhegner, Elizabeth Sabens ^a   Vogt, Caleb D ^b   Sem, Daniel S ^b   Cunningham, Christopher W ^b   Hillard, Cecilia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Pharmaceutical Sciences   (United States)

Author keywords

2 Arachidonoylglycerol; AM404; AutoDock; Cholesterol; N Arachidonylethanolamine; Sequestration; Uptake

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ENDOCANNABINOID; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N ARACHIDONYLETHANOLAMINE; STEROL CARRIER PROTEIN 2; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; CARRIER PROTEIN; CHOLESTEROL; LIPID; N-(4-HYDROXYPHENYL)ARACHIDONYLAMIDE; PROTEIN BINDING; STEROL CARRIER PROTEINS;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; COMPUTER MODEL; CONTROLLED STUDY; EMBRYO; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; MOLECULAR DOCKING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOLUBILITY; STATIC ELECTRICITY; STEADY STATE; WESTERN BLOTTING; HEK293 CELL LINE; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION;

ARACHIDONIC ACIDS; CARRIER PROTEINS; CHOLESTEROL; ENDOCANNABINOIDS; HEK293 CELLS; HUMANS; LIPIDS; NEURONS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84911004168     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8651-7     Document Type: Article

References (42)

1. Katona I, Freund TF (2012) Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 35:529–558. doi:10.1146/annurev-neuro-062111-150420
2. Fowler CJ (2013) Transport of endocannabinoids across the plasma membrane and within the cell. FEBS J 280(9):1895–1904. doi:10.1111/febs.12212
3. Hillard CJ, Jarrahian A (2003) Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol 140(5):802–808
4. Sanchez ER (2012) Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperones. Biochim Biophys Acta 1823(3):722–729. doi:10.1016/j.bbamcr.2011.11.006
5. Muccioli GG (2010) Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today 15(11–12):474–483. doi:10.1016/j.drudis.2010.03.007
6. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM (1998) Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254(3):137–140
7. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, Watanabe M (2006) Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26(18):4740–4751
8. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20(2):441–458
9. Kaczocha M, Glaser ST, Deutsch DG (2009) Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci U S A 106(15):6375–6380. doi:10.1073/pnas.0901515106
10. Oddi S, Fezza F, Pasquariello N, D’Agostino A, Catanzaro G, De Simone C, Rapino C, Finazzi-Agro A, Maccarrone M (2009) Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chem Biol 16(6):624–632. doi:10.1016/j.chembiol.2009.05.004
11. Storch J, Thumser AE (2010) Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem 285(43):32679–32683. doi:10.1074/jbc.R110.135210
12. Boneva NB, Mori Y, Kaplamadzhiev DB, Kikuchi H, Zhu H, Kikuchi M, Tonchev AB, Yamashima T (2010) Differential expression of FABP 3, 5, 7 in infantile and adult monkey cerebellum. Neurosci Res 68(2):94–102. doi:10.1016/j.neures.2010.07.2028
13. Kipp M, Gingele S, Pott F, Clarner T, van der Valk P, Denecke B, Gan L, Siffrin V, Zipp F, Dreher W, Baumgartner W, Pfeifenbring S, Godbout R, Amor S, Beyer C (2011) BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions. Brain Behav Immun 25(8):1554–1568. doi:10.1016/j.bbi.2011.05.003
14. Yenari MA, Giffard RG, Sapolsky RM, Steinberg GK (1999) The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today 5(12):525–531
15. Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, Masetti M, Guijarro A, Lodola A, Armirotti A, Garau G, Bandiera T, Reggiani A, Mor M, Cavalli A, Piomelli D (2012) A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 15(1):64–69. doi:10.1038/nn.2986
16. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci U S A 101:8756–8761
17. Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Schroeder F (2001) Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics. Biochemistry 40(21):6493–6506
18. Schroeder F, Atshaves BP, McIntosh AL, Gallegos AM, Storey SM, Parr RD, Jefferson JR, Ball JM, Kier AB (2007) Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochim Biophys Acta 1771(6):700–718. doi:10.1016/j.bbalip.2007.04.005
19. Avdulov NA, Chochina SV, Igbavboa U, Warden CS, Schroeder F, Wood WG (1999) Lipid binding to sterol carrier protein-2 is inhibited by ethanol. Biochim Biophys Acta 1437(1):37–45
20. Myers-Payne SC, Fontaine RN, Loeffler A, Pu L, Rao AM, Kier AB, Wood WG, Schroeder F (1996) Effects of chronic ethanol consumption on sterol transfer proteins in mouse brain. J Neurochem 66(1):313–320
21. Garcia FL, Szyperski T, Dyer JH, Choinowski T, Seedorf U, Hauser H, Wuthrich K (2000) NMR structure of the sterol carrier protein-2: implications for the biological role. J Mol Biol 295(3):595–603. doi:10.1006/jmbi.1999.3355
22. Moncecchi D, Murphy EJ, Prows DR, Schroeder F (1996) Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptake. Biochim Biophys Acta 1302(2):110–116
23. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–2791. doi:10.1002/jcc.21256
24. Bazeley PS, Prithivi S, Struble CA, Povinelli RJ, Sem DS (2006) Synergistic use of compound properties and docking scores in neural network modeling of CYP2D6 binding: predicting affinity and conformational sampling. J Chem Inf Model 46(6):2698–2708. doi:10.1021/ci600267k
25. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33. doi:10.1186/1758-2946-3-33
26. Kernstock RM, Girotti AW (2007) Lipid transfer protein binding of unmodified natural lipids as assessed by surface plasmon resonance methodology. Anal Biochem 365(1):111–121. doi:10.1016/j.ab.2007.02.018
27. Vila A, Levchenko VV, Korytowski W, Girotti AW (2004) Sterol carrier protein-2-facilitated intermembrane transfer of cholesterol- and phospholipid-derived hydroperoxides. Biochemistry 43(39):12592–12605. doi:10.1021/bi0491200
28. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277(5329):1094–1097
29. Myers-Payne SC, Hubbell T, Pu L, Schnutgen F, Borchers T, Wood WG, Spener F, Schroeder F (1996) Isolation and characterization of two fatty acid binding proteins from mouse brain. J Neurochem 66(4):1648–1656
30. Huang H, Ball JM, Billheimer JT, Schroeder F (1999) The sterol carrier protein-2 amino terminus: a membrane interaction domain. Biochemistry 38(40):13231–13243
31. Butko P, Hapala I, Scallen TJ, Schroeder F (1990) Acidic phospholipids strikingly potentiate sterol carrier protein 2 mediated intermembrane sterol transfer. Biochemistry 29(17):4070–4077
32. Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69(2):631–638
33. Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh AL, Martin GG, Chao H, Kier AB, Schroeder F (2001) Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res 40(6):498–563
34. Hillard CJ, Jarrahian A (2005) Accumulation of anandamide: evidence for cellular diversity. Neuropharmacology 48(8):1072–1078
35. Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci U S A 100(7):4269–4274
36. Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG (2012) Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J Biol Chem 287(5):3415–3424. doi:10.1074/jbc.M111.304907
37. Takaoka N, Takayama T, Teratani T, Sugiyama T, Mugiya S, Ozono S (2011) Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines. BMC Mol Biol 12:31. doi:10.1186/1471-2199-12-31
38. Khasabova IA, Holman M, Morse T, Burlakova N, Coicou L, Harding-Rose C, Simone DA, Seybold VS (2013) Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiol Dis. doi:10.1016/j.nbd.2013.04.018
39. Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A, Serrano A, Baixeras E, Khaturia S, Navarro M, Parsons LH, Piomelli D, Rodriguez de Fonseca F (2007) Regulation of brain anandamide by acute administration of ethanol. Biochem J 404(1):97–104
40. Alvarez-Jaimes L, Stouffer DG, Parsons LH (2009) Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats. J Neurochem 111(1):37–48. doi:10.1111/j.1471-4159.2009.06301.x
41. Masuo Y, Ishido M, Morita M, Sawa H, Nagashima K, Niki E (2007) Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat. Eur J Neurosci 25(12):3659–3666. doi:10.1111/j.1460-9568.2007.05613.x
42. Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M, Tokunaga K (2010) An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet 128(4):433–441. doi:10.1007/s00439-010-0862-z